Table 1.

Demographic and clinicopathological data of the OSCC patient cohort. Significant correlation with an increased serum GP88 level is marked in bold.

Parameter	Subgroup	Serum GP88 < 68 ng/mL	Serum GP88 ≥ 68 ng/mL	n	p
age	<60.5	33	16	49	0.39
	≥60.5	32	15	47
sex	male	46	23	69	0.73
	female	19	8	27
patient status	alive	31	27	58	<0.001
	deceased	34	4	38
T stage	T1	12	9	21	0.44
	T2	22	12	34
	T3	16	4	20
	T4	15	6	21
N stage	N0	38	22	60	0.50
	N1	10	2	12
	N2	16	7	23
	N3	1	0	1
M	M0	64	31	95	0.49
	M1	1	0	1
Grading	1	10	4	14	0.93
	2	40	19	59
	3	15	8	23
radiotherapy	no	43	27	70	0.03
	yes	22	4	26
chemotherapy	no	54	30	84	0.06
	yes	11	1	12

Significant correlation with an increase serum GP88 level is marked in bold.